首页> 外文期刊>Pharmacognosy Research >Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
【24h】

Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms

机译:反相高效液相色谱大剂量和片剂剂型同时估算阿巴卡韦和拉米夫定的分析方法开发与验证

获取原文
           

摘要

Objective: A simple rapid, accurate, precise, and reproducible validated reverse phase high performance liquid chromatography (HPLC) method was developed for the determination of Abacavir (ABAC) and Lamivudine (LAMI) in bulk and tablet dosage forms. Methods: The quantification was carried out using Symmetry Premsil C18 (250 mm × 4.6 mm, 5 μm) column run in isocratic way using mobile phase comprising methanol: water (0.05% orthophosphoric acid with pH 3) 83:17 v/v and a detection wavelength of 245 nm and injection volume of 20 μl, with a flow rate of 1 ml/min. Results: In the developed method, the retention times of ABAC and LAMI were found to be 3.5 min and 7.4 min, respectively. The method was validated in terms of linearity, precision, accuracy, limits of detection, limits of quantitation, and robustness in accordance with the International Conference on Harmonization guidelines. Conclusion: The assay of the proposed method was found to be 99% – 101%. The recovery studies were also carried out and mean % recovery was found to be 99% – 101%. The % relative standard deviation from reproducibility was found to be <2%. The proposed method was statistically evaluated and can be applied for routine quality control analysis of ABAC and LAMI in bulk and in tablet dosage form. SUMMARY Attempts were made to develop RP-HPLC method for simultaneous estimation of Abacavir and Lamivudine for the RP-HPLC method. The developed method was validated according to the ICH guidelines. The linearity, precision, range, robustness were within the limits as specified by the ICH guidelines. Hence the method was found to be simple, accurate, precise, economic and reproducible. So the proposed methods can be used for the routine quality control analysis of Abacavir and Lamivudine in bulk drug as well as in formulations. Abbreviations Used: HPLC: High-performance liquid chromatography, UV: Ultraviolet, ICH: International Conference on Harmonization, ABAC: Abacavir, LAMI: Lamivudine, HIV: Human immunodeficiency virus, AIDS: Acquired immunodeficiency syndrome, NRTI: Nucleoside reverse transcriptase inhibitors, ARV: Antiretroviral, RSD: Relative standard deviation, RT: Retention time, SD: Standard deviation.
机译:目的:建立了一种简便,快速,准确,精确和可重复验证的反相高效液相色谱(HPLC)方法,用于测定散装和片剂剂型中的阿巴卡韦(ABAC)和拉米夫定(LAMI)。方法:使用Symmetry Premsil C18(250 mm×4.6 mm,5μm)色谱柱进行等度洗脱,使用甲醇:水(0.05%正磷酸,pH 3)83:17 v / v进行流动相定量。检测波长为245 nm,进样量为20μl,流速为1 ml / min。结果:在改进的方法中,ABAC和LAMI的保留时间分别为3.5分钟和7.4分钟。根据国际协调会议的指导原则,该方法在线性,精度,准确性,检测限,定量限和鲁棒性方面得到了验证。结论:建议方法的检出率为99%– 101%。还进行了回收率研究,发现回收率的平均百分比为99%– 101%。发现相对于再现性的相对标准偏差%为<2%。对提出的方法进行了统计评估,可用于散装和片剂剂型中ABAC和LAMI的常规质量控制分析。发明内容尝试开发用于同时估算阿巴卡韦和拉米夫定的RP-HPLC方法的RP-HPLC方法。根据ICH指南验证了开发的方法。线性,精度,范围,鲁棒性均在ICH指南规定的范围内。因此,发现该方法简单,准确,精确,经济并且可重复。因此,所提出的方法可用于阿巴卡韦和拉米夫定在原料药和制剂中的常规质量控制分析。使用的缩写:HPLC:高效液相色谱法,UV:紫外线,ICH:国际协调会议,ABAC:阿巴卡韦,LAMI:拉米夫定,HIV:人类免疫缺陷病毒,AIDS:获得性免疫缺陷综合症,NRTI:核苷类逆转录酶抑制剂,ARV :抗逆转录病毒,RSD:相对标准偏差,RT:保留时间,SD:标准偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号